RRM2 and breast cancer: In breast cancer, miR-4500 expression is down-regulated, and exerts anti-cancer effects by attenuating cancer cell migration, invasion and capillary-like tube formation of endothelial cells through regulating RRM2-dependent MAPK signaling pathway [37].